Haider Javed Warraich
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Haider Javed Warraich has a total of 53 co-authors. Here are the top co-authors by number of shared publications:
Robert J. Mentz
Department of Medicine, Duke University Medical Center, Durham, NC; Duke Clinical Research Institute, Durham, NC
5 shared publicationsChetan B. Patel
Department of Medicine, Duke University Medical Center, Durham, NC; Duke Clinical Research Institute, Durham, NC
4 shared publicationsAdrian F. Hernandez
Division of Cardiology, Department of Medicine, Duke University Medical Center, Durham, North Carolina
3 shared publicationsClyde W. Yancy
Department of Medicine, Division of Cardiology, Northwestern Memorial Hospital, Feinberg School of Medicine, Northwestern University, Chicago, Illinois
2 shared publicationsDonald H. Taylor
Duke Clinical Research Institute, Durham, NC; Duke University School of Nursing, Durham, NC; Sanford School of Public Policy, Duke University, Durham, NC; Margolis Center for Health Policy, Duke University, Durham, NC
2 shared publicationsGregg C. Fonarow
Department of Medicine, University of California, Los Angeles
2 shared publications
Latest Publications
- 1 August 2019
- Published by Elsevier in Journal of Cardiac Failure
- Vol. 25 (8) , 693-694
African Americans With Advanced Heart Failure Are More Likely to Die in a Health Care Facility Than at Home or in Hospice: An Analysis From the PAL-HF Trial
- 1 August 2019
- Published by Elsevier in Journal of Cardiac Failure
- Vol. 25 (8) , 693-694
African Americans With Advanced Heart Failure Are More Likely to Die in a Health Care Facility Than at Home or in Hospice: An Analysis From the PAL-HF Trial
- 1 July 2019
- Published by Elsevier in JACC: Heart Failure
- Vol. 7 (7) , 558-560
Failure Is Not an Option
- 1 July 2019
- Published by Elsevier in JACC: Heart Failure
- Vol. 7 (7) , 558-560
Failure Is Not an Option
- Open Access
- 24 May 2019
- Published by Radcliffe Medical Media Ltd in Cardiac Failure Review
- Vol. 5 (2) , 93-98
Hospice Use Among Patients with Heart Failure
Despite its many benefits, hospice care is underused for patients with heart failure. This paper discusses the factors contributing to this underuse and offers recommendations to optimise use for patients with heart failure and proposes metrics to optimise quality of hospice care for this patient group.
- 24 May 2019
- Published by Radcliffe Medical Media Ltd in Cardiac Failure Review
- Vol. 5 (2) , 93-98
Open AccessHospice Use Among Patients with Heart Failure
Despite its many benefits, hospice care is underused for patients with heart failure. This paper discusses the factors contributing to this underuse and offers recommendations to optimise use for patients with heart failure and proposes metrics to optimise quality of hospice care for this patient group.
- 1 April 2019
- Published by SAGE Publications in Journal of Palliative Medicine
- Vol. 22 (4) , 437-441
Top Ten Tips Palliative Care Clinicians Should Know About Caring for Patients with Left Ventricular Assist Devices
Advanced heart failure (HF) is a common condition that leads to significant suffering for patients and their families. Left ventricular assist devices (LVADs) can improve both the quantity and quality of life for those suffering with advanced HF. Palliative care clinicians are being asked with increasing frequency to assist HF teams to manage patients with LVADs in the preimplantation, post-operative, and end-of-life settings, although not all palliative care providers feel comfortable with this technology. Written by specialists in HF, geriatric cardiology, and palliative care, this article seeks to improve palliative care providers' knowledge of LVADs and will prepare palliative care teams to counsel and support LVAD patients and their families from pre-implantation to the end of life.
- 1 April 2019
- Published by SAGE Publications in Journal of Palliative Medicine
- Vol. 22 (4) , 437-441
Top Ten Tips Palliative Care Clinicians Should Know About Caring for Patients with Left Ventricular Assist Devices
Advanced heart failure (HF) is a common condition that leads to significant suffering for patients and their families. Left ventricular assist devices (LVADs) can improve both the quantity and quality of life for those suffering with advanced HF. Palliative care clinicians are being asked with increasing frequency to assist HF teams to manage patients with LVADs in the preimplantation, post-operative, and end-of-life settings, although not all palliative care providers feel comfortable with this technology. Written by specialists in HF, geriatric cardiology, and palliative care, this article seeks to improve palliative care providers' knowledge of LVADs and will prepare palliative care teams to counsel and support LVAD patients and their families from pre-implantation to the end of life.
- 1 January 2019
- Published by SAGE Publications in Journal of Palliative Medicine
- Vol. 22 (1) , 7-8
Hospice Care for Heart Failure: Challenges Faced by Hospice Staff in a Predominantly Rural Setting
- 1 January 2019
- Published by SAGE Publications in Journal of Palliative Medicine
- Vol. 22 (1) , 7-8
Hospice Care for Heart Failure: Challenges Faced by Hospice Staff in a Predominantly Rural Setting
- Open Access
- 2 November 2018
- Published by American Medical Association (AMA) in JAMA Network Open
- Vol. 1 (7) , e184815
Work and Cardiovascular Disease in China
The article by Jiang et al offers essential insights into the factors associated with returning to work after a nonfatal acute myocardial infarction (AMI) among
- 2 November 2018
- Published by American Medical Association (AMA) in JAMA Network Open
- Vol. 1 (7) , e184815
Open AccessWork and Cardiovascular Disease in China
The article by Jiang et al offers essential insights into the factors associated with returning to work after a nonfatal acute myocardial infarction (AMI) among
- 11 October 2018
- Published by Springer Nature in Current Cardiology Reports
- Vol. 20 (12) , 1-7
Diabetic Dyslipidemia: Epidemiology and Prevention of Cardiovascular Disease and Implications of Newer Therapies
Purpose of Review Dyslipidemia in patients with T2DM confers significant additional risk of adverse outcomes to patients with cardiovascular disease (CVD). These patients carry residual risk of adverse outcomes despite optimal management with conventional therapy such as lifestyle changes and statin therapy. The role of both nonstatin monotherapy in statin-intolerant patients and combination therapy with statins in patients with high risk of CVD events has been well studied. We sought to review the role of newer therapies in risk reduction in these patients. Recent Findings Traditionally, non-statin options have included medications such as niacin, ezetimibe, fenofibrate, and n-3 fatty acids. Recently, drugs such as ezetimibe, inclisiran, and PCSK9 inhibitors have been studied with favorable results without an increased risk of developing new-onset diabetes. These medications hold the promise of increasing options to reduce cardiovascular risk in patients with T2DM. Summary The role of newer non-statin therapies in patients with diabetic dyslipidemia in combination with statins needs to be further explored.
- 11 October 2018
- Published by Springer Nature in Current Cardiology Reports
- Vol. 20 (12) , 1-7
Diabetic Dyslipidemia: Epidemiology and Prevention of Cardiovascular Disease and Implications of Newer Therapies
Purpose of Review Dyslipidemia in patients with T2DM confers significant additional risk of adverse outcomes to patients with cardiovascular disease (CVD). These patients carry residual risk of adverse outcomes despite optimal management with conventional therapy such as lifestyle changes and statin therapy. The role of both nonstatin monotherapy in statin-intolerant patients and combination therapy with statins in patients with high risk of CVD events has been well studied. We sought to review the role of newer therapies in risk reduction in these patients. Recent Findings Traditionally, non-statin options have included medications such as niacin, ezetimibe, fenofibrate, and n-3 fatty acids. Recently, drugs such as ezetimibe, inclisiran, and PCSK9 inhibitors have been studied with favorable results without an increased risk of developing new-onset diabetes. These medications hold the promise of increasing options to reduce cardiovascular risk in patients with T2DM. Summary The role of newer non-statin therapies in patients with diabetic dyslipidemia in combination with statins needs to be further explored.
- Open Access
- 1 October 2018
- Published by American Medical Association (AMA) in JAMA Cardiology
- Vol. 3 (10) , 917-926
Trends in Hospice Discharge and Relative Outcomes Among Medicare Patients in the Get With The Guidelines–Heart Failure Registry
Patients with heart failure (HF) report a high symptom burden, and despite therapeutic advances, the median survival among Medicare beneficiaries hospitalized with HF is only 2.1 years.1,2 Therefore, many patients with HF may benefit from palliative care and hospice.
- 1 October 2018
- Published by American Medical Association (AMA) in JAMA Cardiology
- Vol. 3 (10) , 917-926
Open AccessTrends in Hospice Discharge and Relative Outcomes Among Medicare Patients in the Get With The Guidelines–Heart Failure Registry
Patients with heart failure (HF) report a high symptom burden, and despite therapeutic advances, the median survival among Medicare beneficiaries hospitalized with HF is only 2.1 years.1,2 Therefore, many patients with HF may benefit from palliative care and hospice.
- 11 September 2018
- Published by American Medical Association (AMA)
- Vol. 320 (10) , 1037-1038
Generational Differences in Mentoring Relationships
To the Editor The article by Waljee and colleagues on mentoring millennial physicians and researchers1 highlighted the importance of mentoring, but it did not provide context with regard to some underlying assumptions about generational differences, which have been a focus of intense research and social commentary. Systematic reviews of studies assessing generational differences have failed to show any meaningful differences, and these findings have led many large employers to stop applying such labels to their workforce.2-4 Media outlets such as the Wall Street Journal have formally announced that they will not be using the term millennial because of the negative stereotypes that it represents.5 By using this term, the authors risk perpetuating false myths about young people.
- 11 September 2018
- Published by American Medical Association (AMA)
- Vol. 320 (10) , 1037-1038
Generational Differences in Mentoring Relationships
To the Editor The article by Waljee and colleagues on mentoring millennial physicians and researchers1 highlighted the importance of mentoring, but it did not provide context with regard to some underlying assumptions about generational differences, which have been a focus of intense research and social commentary. Systematic reviews of studies assessing generational differences have failed to show any meaningful differences, and these findings have led many large employers to stop applying such labels to their workforce.2-4 Media outlets such as the Wall Street Journal have formally announced that they will not be using the term millennial because of the negative stereotypes that it represents.5 By using this term, the authors risk perpetuating false myths about young people.
- 1 July 2018
- Published by Wolters Kluwer Health in Circulation: Cardiovascular Quality and Outcomes
- Vol. 11 (7) , e004643
Differences Between Patients Enrolled Early and Late During Clinical Trial Recruitment
- 1 July 2018
- Published by Wolters Kluwer Health in Circulation: Cardiovascular Quality and Outcomes
- Vol. 11 (7) , e004643
Differences Between Patients Enrolled Early and Late During Clinical Trial Recruitment